These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 29478918

  • 21. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF, Li X, Xiang HY, Yang H, Lv CY, Sun XL, Chen HZ, Gao Y, Yang JS, Luo W, Yang YQ, Tang YH.
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [Abstract] [Full Text] [Related]

  • 22. Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis.
    McElvaney OJ, Zaslona Z, Becker-Flegler K, Palsson-McDermott EM, Boland F, Gunaratnam C, Gulbins E, O'Neill LA, Reeves EP, McElvaney NG.
    Am J Respir Crit Care Med; 2019 Dec 01; 200(11):1381-1391. PubMed ID: 31454256
    [Abstract] [Full Text] [Related]

  • 23. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes.
    Bakhshi S, Shamsi S.
    Int Immunopharmacol; 2022 May 01; 106():108595. PubMed ID: 35124417
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction.
    Zhang Y, Lv X, Hu Z, Ye X, Zheng X, Ding Y, Xie P, Liu Q.
    Cell Death Dis; 2017 Jul 20; 8(7):e2941. PubMed ID: 28726778
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
    Dolunay A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B.
    Inflammation; 2017 Apr 20; 40(2):366-386. PubMed ID: 27924425
    [Abstract] [Full Text] [Related]

  • 30. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, Fuster JJ, Walsh K.
    J Am Coll Cardiol; 2018 Feb 27; 71(8):875-886. PubMed ID: 29471939
    [Abstract] [Full Text] [Related]

  • 31. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S, Chen Z, Fan B, Chen Y, Zhou L, Jiang B, Long H, Zhong W, Li X, Li Y.
    J Neuroimmunol; 2021 May 15; 354():577543. PubMed ID: 33714750
    [Abstract] [Full Text] [Related]

  • 32. Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome.
    Lowes DJ, Hevener KE, Peters BM.
    Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31712208
    [Abstract] [Full Text] [Related]

  • 33. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
    Zhai Y, Meng X, Ye T, Xie W, Sun G, Sun X.
    Molecules; 2018 Feb 27; 23(3):. PubMed ID: 29495433
    [Abstract] [Full Text] [Related]

  • 34. Role of the NLRP3 inflammasome in a model of acute burn-induced pain.
    Deuis JR, Yin K, Cooper MA, Schroder K, Vetter I.
    Burns; 2017 Mar 27; 43(2):304-309. PubMed ID: 28040362
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice.
    Ludwig-Portugall I, Bartok E, Dhana E, Evers BD, Primiano MJ, Hall JP, Franklin BS, Knolle PA, Hornung V, Hartmann G, Boor P, Latz E, Kurts C.
    Kidney Int; 2016 Sep 27; 90(3):525-39. PubMed ID: 27262364
    [Abstract] [Full Text] [Related]

  • 37. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
    Zhao J, Guo X, Wang B, Yang Z, Huang T, Guo D, Zhang M, Song J.
    Neurochem Res; 2020 Sep 27; 45(9):2020-2031. PubMed ID: 32474832
    [Abstract] [Full Text] [Related]

  • 38. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1-42-stimulated murine astrocytes.
    Ebrahimi T, Rust M, Kaiser SN, Slowik A, Beyer C, Koczulla AR, Schulz JB, Habib P, Bach JP.
    J Neuroinflammation; 2018 Sep 27; 15(1):282. PubMed ID: 30261895
    [Abstract] [Full Text] [Related]

  • 39. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition.
    Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, Schroder K.
    Nat Chem Biol; 2019 Jun 27; 15(6):556-559. PubMed ID: 31086327
    [Abstract] [Full Text] [Related]

  • 40. Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice.
    Yang X, Lu F, Li L, Li J, Luo J, Zhang S, Liu X, Chen G.
    BMC Complement Altern Med; 2019 Jan 31; 19(1):35. PubMed ID: 30704457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.